Aida Pharmaceuticals, Inc. (AIDA)
AIDA Stock Price Chart
Explore Aida Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze AIDA price movements and trends.
AIDA Company Profile
Discover essential business fundamentals and corporate details for Aida Pharmaceuticals, Inc. (AIDA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
26 Sept 2005
Employees
450.00
CEO
Biao Jin
Description
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
AIDA Financial Timeline
Browse a chronological timeline of Aida Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
AIDA Stock Performance
Access detailed AIDA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.